Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Dopamine Function in Human Obesity
NCT03648892Phase 1Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Sep 2018
- Primary completion
- Mar 2022
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Primary endpoints: Correlation Between Striatal D2 Receptor Binding Potential (D2BP) as Measured by [18F]Fallypride and [11C]Raclopride Time-activity Curves, Relationship Between Striatal D2BP and BMI is Quadratic or Linear and 2 more. Started Sep 2018; status: completed.
Beyond the preview
Go deeper on NCT03648892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03648892.